{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:50:20Z","timestamp":1792522220623,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.041","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T15:16:37Z","timestamp":1451315797000},"page":"798-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Inactivation of rabies virus by hydrogen peroxide"],"prefix":"10.1016","volume":"34","author":[{"given":"Asmaa A.","family":"Abd-Elghaffar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal E.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer A.","family":"Boseila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.041_bib0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijid.2003.09.002","article-title":"In vitro inactivation of the rabies virus by ascorbic acid","volume":"8","author":"Shampur","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0165","series-title":"Vaccines","article-title":"Rabies vaccines","author":"Rupprecht","year":"2012"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0170","series-title":"Rabies fact sheet N\u00b099","author":"WHO Media Center","year":"2011"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0175","series-title":"Technical report series no. 982, expert consultation on rabies, second report","author":"WHO","year":"2013"},{"issue":"4","key":"10.1016\/j.vaccine.2015.12.041_bib0180","first-page":"859","article-title":"DNA\u2013protein complexes produced by a carcinogen, beta-propiolactone","volume":"34","author":"Nietert","year":"1974","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0185","first-page":"259","volume":"vol. 4","author":"IRAC (International Agency for Research on Cancer)","year":"1974"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(86)90022-4","article-title":"Relationships between the levels of binding to DNA and the carcinogenic potencies in rat nasal mucosa for three alkylating agents","volume":"33","author":"Snyder","year":"1986","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2015.12.041_bib0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0264-410X(91)90289-I","article-title":"Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children","author":"Siber","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0200","unstructured":"Slifka MK, Carter SV, Erika H, Paul Y. Inactivating pathogens with hydrogen peroxide for vaccine production. USA Patent Application Publication 2007. Pub. No.: US20070031451 A1."},{"issue":"June (6)","key":"10.1016\/j.vaccine.2015.12.041_bib0205","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nm.2763","article-title":"Development of a new hydrogen peroxide-based vaccine platform","volume":"18","author":"Amanna","year":"2012","journal-title":"Nat Med"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2015.12.041_bib0210","first-page":"321","article-title":"Production in Vero cells of an inactivated rabies vaccine from strain FRV\/K for animal and human use","volume":"31","author":"El-Karamany","year":"1987","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0215","series-title":"Guidelines on Euthanasia","author":"American Veterinary Medical Association (AVMA)","year":"2007"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0220","series-title":"Biosafety in microbiological and biomedical laboratories","first-page":"21","year":"2009"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0225","series-title":"Laboratory techniques in rabies","first-page":"80","article-title":"The mouse inoculation test","author":"Koprowski","year":"1996"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0230","series-title":"Laboratory techniques in rabies","first-page":"445","article-title":"Methods for the calculation of titers","author":"Aubert","year":"1996"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2015.12.041_bib0235","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/JVI.02903-12","article-title":"A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice","volume":"87","author":"Pinto","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0240","series-title":"WHO technical report series no. 941, fifty-sixth report; recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","first-page":"104","year":"2007"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0245","series-title":"European Pharmacopoeia 5.0. Abnormal toxicity","first-page":"20609","year":"2005"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0250","series-title":"Laboratory techniques in rabies","first-page":"237","article-title":"\u03b2-Propiolactone-inactivated sheep brain vaccine","author":"Singh","year":"1996"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0255","series-title":"Laboratory techniques in rabies","first-page":"425","article-title":"Simple technique for the collection and shipment of brain specimens for rabies diagnosis","author":"Barrat","year":"1996"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0260","series-title":"Laboratory techniques in rabies","first-page":"88","article-title":"The fluorescent antibody test","author":"Dean","year":"1996"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2015.12.041_bib0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/adt.2008.151","article-title":"Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents","volume":"6","author":"Johnston","year":"2008","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0270","series-title":"Laboratory techniques in rabies","first-page":"389","article-title":"The Essen-ELISA for the determination of the glycoprotein content of inactivated cell-culture rabies vaccines","author":"Thraenharf","year":"1996"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2015.12.041_bib0275","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2002.66.208","article-title":"Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses","volume":"66","author":"Vorndam","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0280","series-title":"Antibodies A laboratory manual","first-page":"570","article-title":"Antibody capture assays detecting and quantitating antibodies using antigen excess assays","author":"Harlow","year":"1988"},{"issue":"1","key":"10.1016\/j.vaccine.2015.12.041_bib0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.provac.2010.03.001","article-title":"Validation of indirect ELISA for quantitative testing of rabies antibodies during production of anti-rabies serum using equines","volume":"2","author":"Salvi","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0290","series-title":"Laboratory techniques in rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0295","series-title":"CDC guideline for disinfection and sterilization in healthcare facilities","year":"2008"},{"key":"10.1016\/j.vaccine.2015.12.041_bib0300","unstructured":"Code of federal regulations CITE:21CFR184.1366, Sec. 184.1366 hydrogen peroxide. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=184.1366."},{"key":"10.1016\/j.vaccine.2015.12.041_bib0305","unstructured":"European Pharmacopoeia5.0. Rabies vaccine for human use prepared in cell cultures. 01\/2005:0216. http:\/\/lib.njutcm.edu.cn\/yaodian\/ep\/EP5.0\/08_monographs_on_vaccines_for_human_use\/Rabies%20vaccine%20for%20human%20use%20prepared%20in%20cell%20cultures.pdf."},{"key":"10.1016\/j.vaccine.2015.12.041_bib0310","unstructured":"U.S. Pharmacopoeia rabies vaccine. http:\/\/www.pharmacopeia.cn\/v29240\/usp29nf24s0_m72910.html."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:20:08Z","timestamp":1567470008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15018381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15018381"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of rabies virus by hydrogen peroxide","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}